Substance P in the human brain

scientific article published on March 1986

Substance P in the human brain is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0306-4522(86)90041-2
P698PubMed publication ID2422595

P2093author name stringCuello AC
Mai JK
Hopf A
Stephens PH
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)709-739
P577publication date1986-03-01
P1433published inNeuroscienceQ15708571
P1476titleSubstance P in the human brain
P478volume17

Reverse relations

cites work (P2860)
Q30446663"Perestroika" in the basal forebrain: opening the border between neurology and psychiatry
Q374850719.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease
Q41668119Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells
Q48280824An immunohistochemical study of neurotransmitter profiles in developing human visual cortex
Q49136032Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography
Q46355804Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation
Q59449478Chapter II Neurobiology and neuropathology of the human hypothalamus
Q36980707Comparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene
Q38805959Corticostriatal circuitry
Q59544688Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans
Q48598794Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS.
Q42467347Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain
Q48318744Differential regulation of substance P and somatostatin in martinotti cells of the developing cat visual cortex
Q48391416Distribution of neurokinin A in the cat diencephalon: An immunocytochemical study
Q67656953Distribution of substance P-like immunoreactive fibres and terminals in the medulla oblongata of the human infant
Q48136897Distribution of substance P-like immunoreactive neurons and terminals throughout the nucleus of the solitary tract in the human brainstem
Q35162929Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers
Q71726132Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens
Q37698126GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen
Q45295460Globus pallidus degeneration and clinicopathological features of Huntington disease
Q34082836Immunocytochemical study of substance P-like cell bodies and fibres in the brain of the rainbow trout, Salmo gairdneri
Q48237961Immunohistochemical characterization of substance P receptor (NK(1)R)-expressing interneurons in the entorhinal cortex.
Q40848213Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system
Q48126020Interaction between substance P and gastrin-releasing peptide on thyrotropin secretion by rat pituitary in vitro
Q48545415Intraventricular Administration of Substance P Induces Unattached Purkinje Cell Dendritic Spines in Rats
Q34413850Involvement of substance P and the NK-1 receptor in human pathology
Q36875936Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain
Q44258700Mapping of alpha-neo-endorphin- and neurokinin B-immunoreactivity in the human brainstem.
Q24798706Mapping of neurokinin-like immunoreactivity in the human brainstem
Q48973883Metabolic activity of the human ventromedial nucleus neurons in relation to sex and ageing
Q48875017Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons
Q51864098Morphologic and immunohistochemical organization of the human habenular complex.
Q34460547Neurobiology and neurochemistry of Rett syndrome
Q48703592Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala
Q42478068Neurochemical heterogeneity of the primate nucleus accumbens
Q35952741Neuropeptides in hypothalamic neuronal disorders
Q35225841Ontogeny of some neuropeptides in the primate brain
Q48172230PE-11, a peptide derived from chromogranin B, in the human brain
Q31160220Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing
Q69016962Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain
Q48164642Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study
Q48770511Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion
Q73316280Quantitative imaging of substance P in the human brain using a brain mapping analyzer
Q40846734Role of central amino acids and peptide-mediated pathways in neurohypophysial hormone release.
Q42458136Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis
Q34899236Sex differences in the neural circuit that mediates female sexual receptivity
Q48151676Subgroups of parkinsonian patients differentiated by peptidergic immunostaining of caudate nucleus biopsies
Q35337407Substance P and neuropsychiatric disorders: an overview
Q48874876Substance P and substance K in the median eminence and paraventricular nucleus of the rat hypothalamus
Q48788439Substance P and substance K in the rat hypothalamus following monosodium glutamate lesions of the arcuate nucleus
Q34973822Substance P immunoreactivity exhibits frequent colocalization with kisspeptin and neurokinin B in the human infundibular region
Q42487386Substance P immunoreactivity in Rett syndrome
Q43590011Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons
Q34409278Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential
Q59328812Substance P- and tyrosine hydroxylase- containing neurom in the human dorsal motor nucleus of the vagus nerve
Q42455135Substance P-containing pyramidal neurons in the cat somatic sensory cortex
Q44800050Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex
Q30470007Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders
Q41209277Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases
Q35109191The Autocrine/Paracrine Regulation of Thyrotropin Secretion
Q48868681The distribution of noradrenaline, serotonin and gamma-aminobutyric acid in the monkey nucleus accumbens
Q34259043The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders
Q38208768The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P.
Q29619828The reward circuit: linking primate anatomy and human imaging
Q38928744The role of the human globus pallidus in Huntington's disease.
Q38486467The striatal mosaic in primates: Patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum
Q61449190Toward a Common Terminology for the Thalamus
Q27322756Ultra-High Field MRI Post Mortem Structural Connectivity of the Human Subthalamic Nucleus, Substantia Nigra, and Globus Pallidus
Q48772014Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain

Search more.